Autolus Therapeutics (AUTL)
undefined
undefined%
At close: undefined
2.49
0.61%
After-hours Dec 13, 2024, 07:22 PM EST

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15
Revenue 1.70M 6.19M 2.33M 242.00K 2.91M 1.05M 1.69M 1.21M 94.11K
Cost of Revenue 6.57M 137.22M 128.65M 134.89M 4.61M 48.30M 1.01M 478.00K -
Gross Profit -4.87M -131.03M -126.32M -134.65M -1.70M -47.25M 684.00K 734.00K 94.11K
Operating Income -195.03M -163.78M -164.21M -168.15M -137.86M -57.53M -23.42M -14.38M -8.11M
Interest Income 13.51M 1.71M 262.00K 536.00K 2.54M 4.12M 84.00K 75.00K 7.93K
Pretax Income -208.40M -173.21M -165.99M -166.26M -139.01M -36.33M -23.38M -14.33M -8.10M
Net Income -208.38M -148.84M -142.10M -142.09M -123.85M -31.11M -19.73M -12.55M -7.46M
Selling & General & Admin 46.74M 31.90M 31.86M 34.97M 39.45M 16.85M 9.10M 5.15M 6.04M
Research & Development 149.98M 141.99M 134.79M 134.89M 105.42M 24.64M 16.01M 10.44M 2.17M
Other Expenses - -166.00K -145.00K -1.47M 4.51M 3.97M -46.00K -26.00K -
Operating Expenses 1.70M 173.72M 166.65M 168.39M 144.87M 41.48M 25.11M 15.59M 8.20M
Interest Expense 45.07M 8.90M 1.10M - - 12.67K - - -
Selling & Marketing Expenses 1.10M - - - - - - - -
Cost & Expenses 196.73M 173.72M 166.65M 168.39M 144.87M 41.48M 25.11M 15.59M 8.20M
Income Tax -19.00K -24.37M -23.89M -24.16M -15.16M -5.21M -3.65M -1.78M 634.51K
Shares Outstanding (Basic) 173.94M 94.99M 72.08M 51.56M 43.07M 31.56M 13.78M 13.78M 13.78M
Shares Outstanding (Diluted) 173.94M 94.99M 72.08M 51.56M 43.07M 31.56M 13.78M 13.78M 13.78M
EPS (Basic) -1.2 -1.57 -1.97 -2.76 -2.88 -0.99 -1.43 -0.91 -0.54
EPS (Diluted) -1.2 -1.57 -1.97 -2.76 -2.88 -0.99 -1.43 -0.91 -0.54
EBITDA -156.77M -135.54M -132.01M -160.51M -134.40M -50.32M -22.41M -13.90M -4.47M
Depreciation & Amortization 6.57M 7.42M 8.55M 5.75M 4.61M 1.71M 1.01M 478.00K 3.64M